Johnson & Johnson says talc-based powder is safe and will still be sold in other countries
WEDNESDAY, May 20, 2020 (HealthDay News) — Lawsuits claiming that talc-based Johnson’s Baby Powder has caused cancer have led to a plunge in sales in the United States and Canada, so Johnson & Johnson said Tuesday it is ending sales of the product in those two countries.
The company said the talc-based powder is safe and will still be sold in other countries, the Associated Press reported.
About 19,400 lawsuits alleging that J&J’s talcum powder caused ovarian cancer or mesothelioma have been launched against the company.
To date, J&J has won 12 cases and lost 15, and there have been seven mistrials. All of the lost cases have either been overturned on appeal or are still being appealed, the AP reported.
Gene Mutation Identified That Increases Lung Cancer Risk 
Residential Context Has Larger Impact on Ovarian Cancer Survival in Black Women 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Family History Drives Cancer Risk in BRCA Test Groups 
Dense Breast Notification Linked to Increase in Use of Supplemental Ultrasound 
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
